Durability of ChAdOx1 nCoV-19 (AZD1222) vaccine and hybrid humoral immunity against variants including omicron BA.1 and BA.4 6 months after vaccination (COV005): a post-hoc analysis of a randomised, phase 1b–2a trial - Concepedia

Concepedia

Publication | Open Access

Durability of ChAdOx1 nCoV-19 (AZD1222) vaccine and hybrid humoral immunity against variants including omicron BA.1 and BA.4 6 months after vaccination (COV005): a post-hoc analysis of a randomised, phase 1b–2a trial

DOI Full Paper Access

25

Citations

38

References

2022

Year

Shabir A. Madhi, Gaurav Kwatra, Simone I. Richardson, Anthonet Koen, Vicky L. Baillie, Clare Cutland, Lee Fairlie, Sherman D. Padayachee, Keertan Dheda, Shaun Barnabas,

The Lancet Infectious Diseases

References

	Year	Citations

Page 1